CymaBay Therapeutics, Inc.
USD32.48
+0.01 (+0.03%)
CEO
Sujal A. Shah
IPO Date
2014-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$32.49
Prev. Close
$32.47
Day Low
$32.48
Day High
$32.50
52W Low
$7.26
52W High
$32.50
Market Cap
$3.73B
Volume
8.35M
| 88,351 |
| $10.00 |
| 22 Mar 2024 | Shah Sujal | director, officer: Chief Executive Officer | D-Return | Disposed | 39,375 | $1.06 |
| 22 Mar 2024 | Shah Sujal | director, officer: Chief Executive Officer | D-Return | Disposed | 50,000 | $1.82 |
| 22 Mar 2024 | Shah Sujal | director, officer: Chief Executive Officer | D-Return | Disposed | 47,916 | $1.72 |
| 22 Mar 2024 | Shah Sujal | director, officer: Chief Executive Officer | D-Return | Disposed | 90,000 | $3.48 |
| 22 Mar 2024 | Shah Sujal | director, officer: Chief Executive Officer | D-Return | Disposed | 621,101 | $9.21 |
| 22 Mar 2024 | Shah Sujal | director, officer: Chief Executive Officer | D-Return | Disposed | 146,875 | $11.69 |
| 22 Mar 2024 | Shah Sujal | director, officer: Chief Executive Officer | D-Return | Disposed | 314,120 | $8.43 |
| 22 Mar 2024 | Shah Sujal | director, officer: Chief Executive Officer | D-Return | Disposed | 536,032 | $4.05 |